Logo image of OLK

OLINK HOLDING AB - ADR (OLK) Stock Price, Forecast & Analysis

USA - NASDAQ:OLK - US6807101000 - ADR

26.08 USD
+0.08 (+0.31%)
Last: 7/9/2024, 9:30:55 PM
26.02 USD
-0.06 (-0.23%)
After Hours: 7/9/2024, 9:30:55 PM

OLK Key Statistics, Chart & Performance

Key Statistics
Market Cap3.24B
Revenue(TTM)170.90M
Net Income(TTM)-33.70M
Shares124.34M
Float41.90M
52 Week High26.09
52 Week Low14.1
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.27
PEN/A
Fwd PE516.44
Earnings (Next)08-07 2024-08-07/amc
IPO2021-03-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


OLK short term performance overview.The bars show the price performance of OLK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10

OLK long term performance overview.The bars show the price performance of OLK in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of OLK is 26.08 USD. In the past month the price increased by 5.8%. In the past year, price increased by 32.12%.

OLINK HOLDING AB - ADR / OLK Daily stock chart

OLK Latest News, Press Relases and Analysis

OLK Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.84 218.53B
DHR DANAHER CORP 28.69 158.40B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 161.67 49.06B
A AGILENT TECHNOLOGIES INC 26.94 41.62B
IQV IQVIA HOLDINGS INC 18.97 37.50B
MTD METTLER-TOLEDO INTERNATIONAL 33.53 28.90B
WAT WATERS CORP 29.87 22.58B
WST WEST PHARMACEUTICAL SERVICES 36.97 18.79B
ILMN ILLUMINA INC 27.68 18.55B
MEDP MEDPACE HOLDINGS INC 41.27 16.58B
TEM TEMPUS AI INC N/A 11.90B
RVTY REVVITY INC 19.36 10.76B

About OLK

Company Profile

OLK logo image Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. The company is headquartered in Uppsala, Uppsala and currently employs 707 full-time employees. The firm offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The firm operates in Sweden and the USA.

Company Info

OLINK HOLDING AB - ADR

Salagatan 16F

Uppsala UPPSALA 75183 SE

CEO: Jon Heimer

Employees: 707

OLK Company Website

Phone: 46184443970

OLINK HOLDING AB - ADR / OLK FAQ

What does OLINK HOLDING AB - ADR do?

Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. The company is headquartered in Uppsala, Uppsala and currently employs 707 full-time employees. The firm offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The firm operates in Sweden and the USA.


Can you provide the latest stock price for OLINK HOLDING AB - ADR?

The current stock price of OLK is 26.08 USD. The price increased by 0.31% in the last trading session.


What is the dividend status of OLINK HOLDING AB - ADR?

OLK does not pay a dividend.


How is the ChartMill rating for OLINK HOLDING AB - ADR?

OLK has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of OLINK HOLDING AB - ADR (OLK) based on its PE ratio?

OLINK HOLDING AB - ADR (OLK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).


Who owns OLINK HOLDING AB - ADR?

You can find the ownership structure of OLINK HOLDING AB - ADR (OLK) on the Ownership tab.


OLK Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to OLK. When comparing the yearly performance of all stocks, OLK is one of the better performing stocks in the market, outperforming 86.3% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OLK Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to OLK. The financial health of OLK is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OLK Financial Highlights

Over the last trailing twelve months OLK reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS decreased by -145.45% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -6.21%
ROE -7.3%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-18.18%
Sales Q2Q%4.71%
EPS 1Y (TTM)-145.45%
Revenue 1Y (TTM)18.16%

OLK Forecast & Estimates

11 analysts have analysed OLK and the average price target is 26.52 USD. This implies a price increase of 1.69% is expected in the next year compared to the current price of 26.08.

For the next year, analysts expect an EPS growth of 39.4% and a revenue growth 13.93% for OLK


Analysts
Analysts49.09
Price Target26.52 (1.69%)
EPS Next Y39.4%
Revenue Next Year13.93%

OLK Ownership

Ownership
Inst Owners0.72%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A